Skip to content

Advertisement

  • Case report
  • Open Access
  • Open Peer Review

Non-traumatic splenic rupture - a rare first presentation of diffuse large B-cell lymphoma and a review of the literature

BMC Cancer201818:779

https://doi.org/10.1186/s12885-018-4702-1

  • Received: 7 November 2017
  • Accepted: 27 July 2018
  • Published:
Open Peer Review reports

Abstract

Background

Cases of non-traumatic splenic rupture are rare and entails a potentially grave medical outcome. Hence, it is important to consider the differential diagnosis of a non-traumatic splenic rupture in patients with acute or insidious abdominal pain. The incidence of rupture in Diffuse B-cell non-Hodgkin Lymphoma is highly infrequent (Paulvannan and Pye, Int J Clin Pract 57:245–6, 2003; Gedik et el., World J Gastroenterol 14:6711–6716, 2008), despite reports of various non-traumatic splenic rupture in the literature (Orloff and Peksin, Int Abstr Surg 106:1-11, 1958; Paulvannan and Pye, Int J Clin Pract 57:245–6, 2003). In this article, we attempt to highlight the features of a rare cause of splenic rupture that might serve as a future reference point for the detection of similar cases during routine clinical practice.

Case presentation

A 40-year-old man presented with 1 week history of left hypochondriac pain associated with abdominal distention. There was no history of preceding trauma or fever. Clinical examination revealed signs of tachycardia, pallor and splenomegaly. He had no evidence of peripheral stigmata of chronic liver disease. In addition, haematological investigation showed anemia with leucocytosis and raised levels of lactate dehydrogenase enzyme. However, peripheral blood film revealed no evidence of any blast or atypical cells. In view of these findings, imaging via ultrasound and computed tomography of the abdomen was performed. The results of these imaging tests showed splenic collections that was suggestive of splenic rupture and hematoma. Patient underwent emergency splenectomy and the histopathological report confirmed the diagnosis as DLBCL.

Conclusions

The occurrence of true spontaneous splenic rupture is uncommon. In a recent systematic review of 613 cases of splenic rupture, only 84 cases were secondary to hematological malignancy. Acute leukemia and non-Hodgkin lymphoma were the most frequent causes of splenic rupture, followed by chronic and acute myelogeneous leukemias. At present, only a few cases of diffuse large B-cell lymphoma (DLBCL) have been reported. The morbidity and mortality rate is greatly increased when there is a delay in the diagnosis and intervention of splenic rupture cases. Hence, there should be an increased awareness amongst both physicians and surgeons that a non-traumatic splenic rupture could be the first clinical presentation of a DLBCL.

Keywords

  • Non-traumatic splenic rupture
  • Lymphoma
  • Non-Hodgkin’s lymphoma

Background

Non-traumatic splenic rupture is a rare clinical presentation with potentially grave medical outcome. Owing to its elusive nature, the recognition of a non-traumatic splenic rupture requires a high index of clinical suspicion [1, 2]. Few incidences of true spontaneous rupture of spleen have been reported in the literature despite its rarity [3, 4]. Conversely, non-traumatic splenic rupture is common and often related to (also known as pathological rupture) a diseased spleen. Common causes of non traumatic splenic rupture include myeloproliferative diseases, vasculitis and infections (such as malaria or infectious mononucleosis). However, diffuse large B-cell lymphoma (DLBCL) remains an obscure cause of splenic rupture that requires unique attention [4, 5].

Case presentation

A 40 year old Malay male was seen at the emergency department with 1 week history of left hypochondriac pain with concurrent abdominal distention. He also complained of loss of appetite and feeling lethargic for 1 month duration. He had no fever, nausea, vomiting, changes in bowel habits or any history of bleeding diathesis. There was no history of trauma. Neither there were any significant past medical history nor family history of malignancy. He was an active smoker for 20 years but denied any alcohol consumption or substance abuse.

On clinical examination, he was afebrile, with an elevated heart rate of 110 beats per minute and a blood pressure measurement of 121/79 mmHg. Patient appeared pale. Abdominal examination revealed enlarged, non-tender liver and spleen. There was no ascites or peripheral lymphadenopathy. Cardiovascular and respiratory examinations were otherwise unremarkable.

Haematological investigation revealed a low haemoglobin level at 6.4 g/dl. The patient had a white cell count (WCC) of 33.3 × 10^3 /uL and a platelet count of 568 × 10^3/uL. Differential WCC showed a predominant neutrophil count of 79.9%, lymphocyte count 8.9%, monocytes 9.6%, eosinophils 0.8%, basophils 0.8%, absolute neutrophil count of 25.63 × 10^3 /uL and absolute lymphocyte count of 2.95 × 10^3 /uL. There was an increase in lactate dehydrogenase levels (LDH) from 534 to 666 u/L. Peripheral blood film revealed leucocytosis with neutrophilia with no evidence of blast cells or atypical lymphocytes. Patient was reluctant to undergo a bone marrow aspiration and trephine biopsy. Abdominal ultrasonography demonstrated a large splenic collection. A contrast enhanced computerized tomography of the abdomen further revealed a large heterogenous splenic collection measuring 18 cm × 15 cm × 16.9 cm which was suggestive of a splenic haematoma [Fig. 1, 2 and 3]. There were no intra abdominal or pelvic lymph nodes enlargement. Based on computed tomography findings, a preliminary diagnosis of spontaneous splenic rupture was made. A surgical consult was obtained and an explorative laparotomy was performed on the patient. Intra operative findings showed a ruptured spleen with extensive adhesions to the omentum. No intra peritoneal lymph nodes enlargement were found. Splenectomy was then performed and subsequently, the patient was transferred to intensive care unit for close observation.
Fig. 1
Fig. 1

Contrast enhanced Computed Tomography of Thorax, Abdomen and Pelvis showing the abnormal spleen

Fig. 2
Fig. 2

Contrast enhanced Computed Tomography of Thorax, Abdomen and Pelvis showing the abnormal spleen

Fig. 3
Fig. 3

Contrast enhanced Computed Tomography of Thorax, Abdomen and Pelvis showing the abnormal spleen

From a histological perspective, the gross appearance of the obtained specimen revealed an enlarged spleen with irregular outer surfaces. A cut section of the spleen showed a firm, cream coloured layer occupying almost entire spleen with large area of necrosis with splenic infarcts. There as minimal amount of normal looking parenchyma tissues at the peripheral aspect of the specimen. Further histological examination revealed a diffuse infiltration of malignant lymphoid cells, which exhibited irregular nuclear membrane with vesicular nuclear chromatin and prominent nucleoli. The adjacent splenic parenchyma showed a congested and expanded red pulp with infiltration by atypical lymphoid cells [Fig. 4].
Fig. 4
Fig. 4

Intra operative image of the pathological spleen

The histological report confirmed the presence of diffuse large B-cell non-Hodgkin’s lymphoma (NHL) via immunohistochemical testing. Immunohistochemical staining showed the cells to be positive to CD20 (diffuse), BCL-2, BCL-6 (> 30%), and MUM-1 (> 30%) and negative to CD3, CD10, Cyclin-D1, Tdt, CD30 and ALK. Ki67 proliferative index was > 80%. In accordance with the WHO classification of Lymphoid Neoplasm [6, 7], these findings were consistent with the diagnosis of a diffuse large B-cell non-Hodgkin’s lymphoma, non-germinal center B-cell (non-GCB) type. Further molecular studies to assess MYC / BCL-2 / BCL-6 translocation or rearrangement was not done as the fluorescence in situ hybridization (FISH) analysis was not available in our local laboratory settings. Thirteen days later, the patient was discharged with prophylactic meningococcal, pneumococcal and influenza vaccinations. He was referred to the haemato-oncologist outpatient clinic at a tertiary care centre for post - operative chemotherapy. Unfortunately, the patient did not turn up for subsequent follow ups, rendering it difficult to further document any information with regards to treatment response in this report.

Discussion and conclusion

There is a variation in symptom manifestation in patients with splenic rupture. The presence of abdominal pain in splenic rupture has been frequently reported [8]. Abdominal pain, tenderness in the epigastrium and discomfort in the left upper quadrant may be seen in patients who has experienced minor injury [9]. In 20% of the cases, a sharp radiating pain to the left shoulder (Kehr’s sign) was observed [9]. In larger splenic injuries, signs of hypovolemic shock was a common presentation [10]. The clinical signs of shock include tachycardia, rapid breathing, paleness, reduced capillary filling time and hypotension [10]. In the absence of trauma, clinicians should exercise a high index of suspicion to rule out other rare causes of splenic rupture.

Bassler et al. documented 613 cases of splenic rupture ranging from cases without any antecedent cause to cases with the presence of obvious risk factors (Table 1). The aetiology of atraumatic splenic ruptures were listed in the decreasing order of prevalence as follows: infectious (mainly malaria and infectious mononucleosis), medical procedures related (mostly related to colonoscopy), haematological (commonly non-Hodgkin Lymphoma and Acute Lymphoblastic Leukemia), neoplastic disease, medication related (anti coagulation and thrombolytics), pregnancy-related and others. Majority of these cases had a haematological origin (13.7% of the reported cases) [11]. NHL was reported as the cause for splenic rupture in 6.3% of the reported cases of atraumatic splenic rupture [11]. Based on this systematic review, compounded with other evidence [4, 8, 12], we identified only a handful of splenic rupture that can be attributed to diffuse large B-cell lymphoma [1333]. Other subtypes of non-Hodgkin lymphoma (splenic T cell lymphoma, blastic variant Mantle cell lymphoma, Mantle cell lymphoma, anaplastic large cell lymphoma, unspecified malignant lymphoma and hepatosplenic gamma delta T cell lymphoma) were reported with similar prevalence rates [1333]. Cases of diffuse histiocytic lymphoma, follicular low grade lymphoma, malignant lymphomonocytic B-cell lymphoma and diffuse histiocytic lymphoma were reported infrequently [1333].
Table 1

Overview of different causes of non-traumatic splenic rupture [11]

Categorization of causes

Number of cases reported (n)

Following a medical procedure

112

Infectious disease related

143

Haematological disease related

84

Rheumatological disease related

10

Pregnancy related

38

Non haematological neoplastic

48

Medication related

47

Internal trauma

17

Infiltrative disease

39

Related to splenic or adjacent physical abnormality

31

Miscellanous

44

TOTAL

613 CASES

In another review by P. Renzulli et al. [12] demonstrated a total of 845 patients who had experienced splenic rupture between the year 1980 to 2008. The six major aetiological groups were classified as follows: neoplastic (30.3%), infectious (27.3%), inflammatory, non-infectious (20%), drug or treatment related (9.2%), and normal spleen - idiopathic (7%) [12]. non-Hodgkin Lymphoma and acute Myeloid Leukemia were reported as a common finding among the neoplastic related atraumatic splenic ruptures [34]. The review also noted that the neoplastic subgroup was significantly associated with increased mortality rates [12, 34].

Non-traumatic splenic rupture secondary to haematological malignancies is still widely considered as an uncommon occurence [35]. Nonetheless, limited case reports advocate early recognition and intervention of this rare cause of splenic rupture [8, 36, 37]. In addition, several authors have attributed the low index of suspicion as a major reason for the delayed diagnosis of similar cases of spontaneous splenic rupture secondary to NHL [36, 38, 39]. To that effect, our case report presents rare descriptions where splenic rupture was detected as the first manifestation of a DLBCL [11, 1333, 4042].

Diffuse large B-cell lymphoma (DLBCL) is the commonest and also the most aggressive form of NHLs, accounting for at least 30% of the NHLs [43].The cancer of B lymphocytes can be fatal if left untreated [43]. Extranodal involvement is seen in only 30% of the cases [43]. Although it is thought to occur equally in all age groups, DLBCL appears to affect a predominantly middle age population [43]. Risk factors for developing DLBCL include evidence of family history of lymphoma, autoimmune disease, human immunodeficiency virus infection, hepatitis C virus seropositivity, high body mass and certain occupational exposures. The suggested mechanism of a non-traumatic splenic rupture in lymphoma include splenic enlargement, cellular infiltration, and eventual splenic infarction with associated capsular haemorrhage [44]. Although splenic enlargement itself poses the greatest risk for non-traumatic splenic rupture, there are also other factors that could possibly explain the reasons for a splenic rupture [44].

Initial presentation with B symptoms (fever, night sweats and significant weight loss) accounts for one third of the cases [45]. In most patients, the prevalent clinical findings are peripheral lymphadenopathy with an enlarged spleen [45]. Patients also can present with advanced extranodal disease on admission [45]. However, the combination of rare manifestation [splenic rupture, primary liver lymphoma and the presence of the Asian variant of intravascular lymphoma (AIVL)] often delays the diagnosis of the underlying malignancy [45].

The gold standard for the diagnosis diffuse large B-cell lymphoma (DLBCL) is dependent upon surgical excision biopsy of the lesion [45, 46]. Additional test that help the diagnosis include immunophenotyping using immunohistochemistry or flow cytometry or a combination of both techniques [46].The staging of NHL is in accordance to WHO classification of Lymphoid Neoplasm [6, 7]. At present, full contrast enhanced staging computerized tomography (CT) of the neck, chest, abdomen and pelvis is the modality of choice for staging such patients [46]. In addition, cases where central nervous system involvement (CNS) is suspected, lumbar puncture for cerebral fluid analysis is also required [46]. Recently, fluorodeoxyglucose positron emission tomography (FDG-PET) is strongly recommended as PET scan is more sensitive, especially for extra nodal disease and improve staging accuracy and subsequent response assessment[4648].

In our case, patient’s immunohistochemical staining showed the cells to be positive to CD20 (diffuse), BCL-2, BCL-6 (> 30%), and MUM-1 (> 30%) and negative to CD3, CD10, Cyclin-D1, Tdt, CD30 and ALK. Ki67 proliferative index was > 80%. These findings were consistent with a diffuse large B-cell lymphoma, non-Germinal centre B-cell (non-GCB) type [45, 46]. Further molecular studies, using fluorescence in situ hybridization (FISH) analysis to study MYC and/or BCL-2 or BCL-6 translocation or rearrangement can help clinicians to decide most suitable chemotherapy regimes, as well as prognosticate patient outcome [49].

Chemotherapy forms the cornerstone in the therapy of B-cell lymphoma, both as curative and palliative options. Patients often present with disseminated disease upon diagnosis, making radiation therapy of limited efficacy at this stage of the disease [4446].Chemotherapy regime such as R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisolone) and R-ACVBP (rituximab, doxorubicin, cyclophosphamide, vindesine, bleomycin, prednisolone) are stratified according to age, international prognostic index and feasibility of dose -intensified approaches [4446].The post therapy follow-up plays a vital role in evaluation of treatment response and possible relapses.

In summary, it is evident that a non-traumatic spontaneous splenic rupture is a rare first clinical manifestation of a DLBCL. In our case, the diagnosis was delayed and only confirmed via histopathological findings. Thus, in cases where the initial workup does not point towards a surgical cause, clinicians should raise the suspicion of an underlying malignancy. In such scenarios, urgent ultrasonography and contrast enhanced tomography are the ideal diagnostic modalities to avoid misdiagnosis and delay in intervention which can be fatal.

Abbreviations

DLBCL: 

Diffuse large B-cell non-Hodgkin lymphoma

NHL: 

Non-Hodgkin’s lymphoma

Declarations

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Authors’ contributions

KK, TSCL and CPW participate in the literature review, KK and CPW in data collection, KK and TSCL manuscript writing and review. All authors read and approved the final manuscript.

Ethics approval and consent to participate

NA

Consent for publication

The patient has given written consent for the publication of all of the information contained in this case report.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Department of Internal Medicine, Hospital Enche Besar Hajjah Khalsom, Kluang, Johor, Malaysia
(2)
Department of Medicine, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, 43400 Serdang, Malaysia

References

  1. Orloff MJ, Peksin GW. Spontaneous rupture of the normal spleen; a surgical enigma. Int Abstr Surg. 1958;106(1):1–11.PubMedGoogle Scholar
  2. Paulvannan S, Pye JK. Spontaneous rupture of a normal spleen. Int J Clin Pract. 2003;57(3):245–6.PubMedGoogle Scholar
  3. Gedik E, Girgin S, Aldemir M, Keles C, Tuncer MC, Aktas A. Non traumatic splenic rupture : report of seven cases and review of the literature. World J Gastroenterol. 2008;14(43):6711–6.View ArticlePubMedPubMed CentralGoogle Scholar
  4. Biswas S, Keddington J, McClanathan J. Large B- Cell lymphoma presenting as acute abdominal pain and spontaneous splenic rupture; A case report and review of relevant literature. World J Emerg Surg. 2006;1:35.View ArticlePubMedPubMed CentralGoogle Scholar
  5. Galhotra R, Kaur S, Gupta K, Kalia V. Case report - Spontenous splenic rupture - a rare complication of haematological malignancies. Indian J Surg Oncol. 2011;2(1):27–30.View ArticlePubMedPubMed CentralGoogle Scholar
  6. Jiang M, Bennani NN, Feldman AL. Lymphoma classification update: T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms. Expert Rev Hematol. 2017 mar;10(2):239–49.View ArticlePubMedPubMed CentralGoogle Scholar
  7. Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zalenetz AD, Jaffe ES. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127(20):2375–90.View ArticlePubMedPubMed CentralGoogle Scholar
  8. Biswas S, Keddington J, McClanathan J. Large B Cell Lymphoma presenting as an acute abdominal pain and spontaneous splenic rupture; A case report and review of relevant literature. World J Emerg Surg. 2006;1:35.View ArticlePubMedPubMed CentralGoogle Scholar
  9. Söyüncü S, Bektaş F, Cete Y. Traditional Kehr's sign: Left shoulder pain related to splenic abscess. Ulusal travma ve acil cerrahi dergisi= Turkish journal of trauma & emergency surgery: TJTES. 2012;18(1):87–8.Google Scholar
  10. Hunt JP, Lentz CW, Cairns BA, et al. Management and outcome of splenic injury: the results of a five-yearstatewide population-based study. Am Surg. 1996;62:911–7.PubMedGoogle Scholar
  11. Aubrey-Bassler FK, Sowers N. 613 cases of splenic rupture without risk factors or previously diagnosed disease : a systematic review. BMC Emerg Med. 2012;12:11.View ArticlePubMedPubMed CentralGoogle Scholar
  12. Renzulli P, Hostettler A, Schoepfer AM, Gloor B, Candinas D. Systematic review of atraumatic splenic rupture. Br J Surg. 2009;96:1114–21.View ArticlePubMedGoogle Scholar
  13. Torricelli P, Coriani C, Marchetti M, Rossi A, Manenti A. Spontaneous rupture of the spleen: report of two cases. Abdom Imaging. 2001;26(3):290–3.View ArticlePubMedGoogle Scholar
  14. Andrews DF, Hernandez R, Grafton W, Williams DM. Pathologic rupture of the spleen in non-Hodgkin's lymphoma. Arch Intern Med. 1980;140(1):119–20.View ArticlePubMedGoogle Scholar
  15. Dobashi N, Kuraishi Y, Kobayashi T, Hirano A, Isogai Y, Takagi K. Spontaneous splenic rupture in a case of non-Hodgkin's lymphoma. RinshoKetsueki. 1993;34(2):190–3.Google Scholar
  16. Haj M, Zaina A, Wiess M, Cohen I, Joseph M, Horn I, Eitan A. Pathologic-spontaneous-rupture of the spleen as a presenting sign of splenic T-cell lymphoma - Case report with review. Hepato-Gastroenterology. 1999;46(25):193–5.PubMedGoogle Scholar
  17. Lunning MA, Stetler-Stevenson M, Silberstein PT, Zenger V, Marti GE. Spontaneous (pathological) splenic rupture in a blastic variant of mantle cell lymphoma: a case report and literature review. Clin Lymphoma. 2002;3(2):117–20.View ArticlePubMedGoogle Scholar
  18. Mason KD, Juneja SK. Spontaneous rupture of the spleen as the presenting feature of the blastoid variant of mantle cell lymphoma. Clin Lab Haematol. 2003;25(4):263–5.View ArticlePubMedGoogle Scholar
  19. Salmi R, Gaudenzi P, Di Todaro F, Morandi P, Nielsen I, Manfredini R. When a car accident can change the life: splenic lymphoma and not post-traumatic hematoma. Intern Emerg Med. 2008;3(3):301–2.Google Scholar
  20. Salmi R, Guadenzi P, DiTodaro F, Morandi P, Nielsen I, Manfredini R. When a car accident can change the life: Splenic lymphoma and not post-traumatic haematoma. Intern Emerg Med. 2008;Google Scholar
  21. Strickland AH, Marsden KA, McArdle J, Lowenthal RM. Pathologic Splenic Rupture as the Presentation of Mantle Cell Lymphoma. Leuk Lymphoma. 2001;41(1):197–10.View ArticlePubMedGoogle Scholar
  22. Zieren J, Paul M, Scharfenberg M, Müller JM. The spontaneous splenic rupture as first manifestation of mantle cell lymphoma, a dangerous rarity. Am J Emerg Med. 2004;22(7):629–31.View ArticlePubMedGoogle Scholar
  23. Chen JH, Chan DC, Lee HS, Liu HD, Hsieh CB, Yu JC, Liu YC, Chen CJ. Spontaneous splenic rupture associated with hepatosplenicgammadelta T-cell lymphoma. J Formos Med Assoc. 2005;104(8):593–6.PubMedGoogle Scholar
  24. Narasimhan P, Hitti IF, Gheewala P, Pulakhandam U, Kanzer B. Unusual presentations of lymphoma: Case 3. Splenic hematoma associated with non-Hodgkin's lymphoma. J Clin Oncol. 2002;20:1946–7.View ArticlePubMedGoogle Scholar
  25. Thomson WHF. Diffuse lymphocytic lymphoma with splenic rupture. Postgrad Med J. 1969;45:50–1.View ArticlePubMedPubMed CentralGoogle Scholar
  26. Chappuis J, Simoens C, Smets D, Duttmann R, Mendes da Costa P. Spontaneous rupture of the spleen in relation to a non-Hodgkin lymphona. Acta Chir Belg. 2007;107:446–8.View ArticlePubMedGoogle Scholar
  27. Hebeda KM, MacKenzie MA, van Krieken JH. A case of anaplastic lymphoma kinase-positive anaplastic large cell lymphoma presenting with spontaneous splenic rupture: an extremely unusual presentation. Virchows Arch. 2000;437:459–64.View ArticlePubMedGoogle Scholar
  28. Soria-Aledo V, Aguilar-Domingo M, Garcia-Cuadrado J, Carrasco-Prats M, Gonzalez-Martinez P. Spontaneous rupture of the spleen. A rare form of onset of non-Hodgkin's lymphoma. Rev Clin Esp. 1999;199:552–3.PubMedGoogle Scholar
  29. Roncella S, Cutrona G, Truini M, Airoldi I, Pezzolo A, Valetto A, Di Martino D, Dadati P, De Rossi A, Ulivi M, Fontana I, Nocera A, Valente U, Ferrarini M, Pistoia V. Late Epstein-Barr virus infection of a hepatosplenic gamma delta T-cell lymphoma arising in a kidney transplant recipient. Haematologica. 2000;85(3):256–62.PubMedGoogle Scholar
  30. Tanaka M, Minato T, Yamamura Y, Katayama K, Ishikura H, Ichimori T, et al. A case of non-Hodgkin lymphoma presenting with spontaneous splenic rupture. Tokushima Red Cross Hospital Medical Journal. 2008;13:91–5.Google Scholar
  31. Matsui H, Andou S, Sakakibara K, Tsuji H, Uragami T, Karamatsu S, et al. A case of spontaneous splenic rupture due to malignant lymphoma. Jpn J Gastroenterol Surg. 1994;27:2166–70.View ArticleGoogle Scholar
  32. Fausel R, Sun NCJ, Klein S. Splenic rupture in a human immunodeficiency virus-infected patient with primary splenic lymphoma. Cancer. 1990;66(44):2414–6.View ArticlePubMedGoogle Scholar
  33. Hoar FJ, Chan S, Stonelake PS, Wolverson RW, Bareford D. Splenic rupture as a consequence of dual malignant pathology: a case report. J Clin Pathol. 2003;56(9):709–10.View ArticlePubMedPubMed CentralGoogle Scholar
  34. Moraleda JM, Vazquez ML, Vidriales MB, Hernandez JM, del Canizo C, San Miguel J. Non traumatic rupture of the spleen in malignant hemopathies - 2 new cases. Sangre (Barc ). 1990;35(6):477–9.Google Scholar
  35. Khan SA, et al. An unusual presentation of non pathological delayed splenic rupture : a case report. Cases J. 2009;2:6450.View ArticlePubMedPubMed CentralGoogle Scholar
  36. Griffiths JD, Ding JC, Juneja SK, Thomas RJ, MArtin JJ, Cooper IA. Pathological rupture of the spleen in transforming non Hodgkin lymphoma. Med J Aust. 1986;144(3):146–7,150.PubMedGoogle Scholar
  37. Andrews DF, Hernandez R, Grafton W, Williams DM. Pathological rupture of spleen in non Hodgkin's lymphoma. Arch Intern Med. 1980;140(1):119–20.View ArticlePubMedGoogle Scholar
  38. Chappuis K, Simoens C, Smets D, Duttmann R, Mendes da Costa P. Spontaneous rupture of the spleen in relation to a non Hodgkin lymphoma. Acta Chir Belg. 2007;107(4):446–8.View ArticlePubMedGoogle Scholar
  39. Gennai A, Basili G, Lorenzetti L, Crocetti G, Filidei M, Orciuola E, Prosperi V, Goletti O. Spontaneous rupture of the spleen in non Hodgkin lymphoma : a case report. Chir Ital. 2008;60(5):739–44.PubMedGoogle Scholar
  40. Mohammed A, Majid ZI, Villatoro EA. Spontaneous rupture of the spleen as a result of primary splenic lymphoma. J Surg Case Rep. 2016;2016(1).Google Scholar
  41. Bauer TW, Haskins GE, Armitage JO. Splenic rupture in patients with hematologic malignancies. Cancer. 1981;48(12):2729–33.View ArticlePubMedGoogle Scholar
  42. Jafferbhoy S, Chantry A, Atkey N, Turner D, Wyld L. Unusual presentation of more common disease/injury: Spontaneous splenic rupture: an unusual presentation of CML. BMJ Case Rep. 2011;2011.Google Scholar
  43. Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, Walewski J, André M, Johnson PW, Pfreundschuh M, Ladetto M. Diffuse large B cell lymphoma: ESMO Clinical Practise Guidelines for diagnosis, treatment and follow up. Ann Oncol. 2015;26(Suppl 5):v116–25.View ArticlePubMedGoogle Scholar
  44. Kumar V, Soni P, Dave V, Harris J. Unusual presentation of diffuse large b cell lymphoma with splenic infarcts. J Ingestiq Med High Impact Case Rep. 2017;5(1):2324709617690748.Google Scholar
  45. Cheson BD, Fisher RI, Sf B, et al. Recommendations for initial evaluation, staging, and response assessment Hodgkin and non-Hodgkin of lymphoma: the Lugano classification. J Clin Oncol. 2014;32(27):3059–68.View ArticlePubMedPubMed CentralGoogle Scholar
  46. Chaganti S, Illidge T, Barrington S, Mckay P, Linton K, Cwynarski K, McMillan A, Davies A, Stern S, Peggs K, the British Committee for Standards in Haematology. Guidelines for the management of diffuse large B-cell lymphoma. Br J Haematol. 2016;174:43–56.View ArticlePubMedGoogle Scholar
  47. Barrington SF, Mikhaeel NG. PET scans for staging and restaging in diffuse large B-cell and follicular lymphomas. Current Hematologic Malignancy Reports. 2016;11:185–95.View ArticlePubMedPubMed CentralGoogle Scholar
  48. Keromnes N, Roux PYL, Tempescul A, Abgral R, Robin P, et al. FDG PET/CT for initial staging of diffuse large B-cell lymphoma: is diffuse bone marrow uptake a reflection of disease involvement? J Bone Res. 2016;4:164.Google Scholar
  49. Johnson NA, Savage KJ, Ludkovski O, Ben-Neriah S, Woods R, Steidl C, Dyer MJS, Seibert R, Kuruvilla J, Klasa R, Connors JM, Gascoyne RD, Horsman DE. Lymphomas with concurrent BCL2 and MYC translocations : the clinical factors associated with survival. Blood. 2009;114(11):2273–9.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2018

Advertisement